| __timestamp | Regeneron Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 72471000 |
| Thursday, January 1, 2015 | 838526000 | 89204000 |
| Friday, January 1, 2016 | 1177697000 | 106010000 |
| Sunday, January 1, 2017 | 1320433000 | 137905000 |
| Monday, January 1, 2018 | 1556200000 | 159888000 |
| Tuesday, January 1, 2019 | 1834800000 | 158425000 |
| Wednesday, January 1, 2020 | 1346000000 | 200677000 |
| Friday, January 1, 2021 | 1824900000 | 304759000 |
| Saturday, January 1, 2022 | 2115900000 | 377221000 |
| Sunday, January 1, 2023 | 2631300000 | 336361000 |
| Monday, January 1, 2024 | 2954400000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, understanding the financial strategies of industry leaders is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Regeneron has seen a staggering 421% increase in SG&A expenses, reflecting its aggressive expansion and marketing strategies. In contrast, Supernus Pharmaceuticals, Inc. has experienced a 364% rise, indicating a more measured growth approach.
These trends underscore the diverse strategies employed by these companies in navigating the pharmaceutical landscape.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.